Rezlidhia Capsule
Product Images NDC 71332-005

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Rezlidhia (NDC 71332-005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rigel Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

150 mg Tablet 30-count Carton Label (Principal Display Panel)

Label for REZLIDHIA capsules, containing olutasidenib 150 mg per capsule. The label indicates it is a prescription drug with a package quantity of 30 capsules. The labeler is Rigel Pharmaceuticals, Inc.*

FDA Label Image

Chemical Structure (Struct 01)

Chemical structure diagram of olutasidenib, the active ingredient in REZLIDHIA capsules. The structure shows a chlorinated aromatic ring, amide bonds, and a nitrile group within its molecular framework.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.